mp1032
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2016 (NCT02908347)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mp1032
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04932941 | Phase 2 | Sep 30, 2021 | MetrioPharm AG, Syneos Health |
| NCT03706209 | Phase 2 | Feb 27, 2018 | Bioskin GmbH, MetrioPharm AG |
| NCT02908347 | Phase 2 | May 1, 2016 | MetrioPharm AG, Parexel |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MetrioPharm AG | For profit | 3 | 3 | 1 | 2016 |
| Bioskin GmbH | For profit | 1 | 0 | 1 | 2018 |
| Parexel | For profit | 1 | 0 | 1 | 2016 |
| Syneos Health | For profit | 1 | 0 | 1 | 2021 |
4 organizations
Page 1 / 1